What Happened?
Baltimore, MD-based Paragon Bioservices Appointed Thomas VanCott as Chief Technology and Strategy Officer
About the Company
Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon`s aim is to build strong client partnerships with the world`s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic protein, and other complex biologics.
About the Person
Thomas VanCott is Chief Technology and Strategy Officer at Paragon Bioservices. Previously, Thomas held various senior IT leadership roles in the industry.
Info Source
News
Short Profile